Progyny (PGNY)
(Delayed Data from NSDQ)
$28.25 USD
-0.19 (-0.67%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $28.26 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
PGNY 28.25 -0.19(-0.67%)
Will PGNY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PGNY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PGNY
Enhabit (EHAB) Beats Q1 Earnings Estimates
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Tops Revenue Estimates
PGNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Progyny (PGNY) is an Incredible Growth Stock: 3 Reasons Why
Earnings Preview: Charles River Laboratories (CRL) Q3 Earnings Expected to Decline
Earnings Preview: Progyny (PGNY) Q3 Earnings Expected to Decline
Other News for PGNY
Progyny, Inc. to Host 2024 Inaugural Investor Day
Progyny’s Strategic Acquisitions and Global Expansion Forecast Positive Growth
Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), Recursion Pharmaceuticals (RXRX) and Progyny (PGNY)
Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl
Progyny acquires Berlin-based Apryl